Elsevier

Chemico-Biological Interactions

Volume 300, 25 February 2019, Pages 82-90
Chemico-Biological Interactions

miR-145-5p is associated with smoke-related chronic obstructive pulmonary disease via targeting KLF5

https://doi.org/10.1016/j.cbi.2019.01.011Get rights and content

Highlights

  • miR-145-5p is down-regulated in the lungs from smokers with COPD.

  • miR-145-5p alleviates CSE-induced apoptosis and inflammation in HBECs.

  • KLF5 is a direct target for miR-145-5p.

  • Restoration of KLF5 enhances CES-induced apoptosis and inflammation in HBECs.

  • miR-145-5p inhibits CSE-induced NF-κB signaling activation.

Abstract

Increasing evidence illustrate that dysregulation of microRNAs (miRNAs) is involved in the pathogenesis of chronic obstructive pulmonary disease (COPD), which is mainly resulted from cigarette smoke (CS) exposure. However, the role of miR-145-5p in CS-mediated COPD remains largely unknown. Thus, the aim of this study was to investigate the expression level of miR-145-5p in 31 human lung tissues samples, and to explore its regulatory role in the apoptosis and inflammation of human bronchial epithelial cells (HBECs) following CS extract (CSE) exposure. We found that miR-145-5p was significantly down-regulated in lung tissues from smokers without or with COPD compared to non-smokers. Functional assays showed that miR-145-5p overexpression remarkably alleviated CSE-induced apoptosis and inflammation response by regulating p53-mediated apoptotic signaling and pre-inflammatory factors such as necrosis factor-α (TNF-α), interleukins (IL)-6, IL-8 in HBECs, whereas, down-regulation of miR-145-5p showed opposite effects. Furthermore, luciferase reporter assays verified that Kruppel-like 5 (KLF5) was a direct target of miR-145-5p. Western blot assay also confirmed that KLF5 was up-regulated in COPD tissues and was negatively associated with miR-145-5p expression. Restoration of miR-145-5p expression significantly abrogated the suppressive effect of miR-145-5p on CSE-stimulated apoptosis and inflammation. In addition, the CSE-induced NF-κB signaling activation was suppressed by miR-145-5p overexpression. Therefore, our data suggested that miR-145-5p conferred protection against CSE-induced airway epithelial cell apoptosis and inflammation partially via targeting KLF5, which might be a potential therapeutic biomarker in COPD treatment.

Introduction

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality every year globally and predicted to be the third leading cause of death by 2030 [1]. CPOD is characterized by chronic bronchiolitis and emphysema due to the abnormal inflammatory response triggered by pollutants such as virus infection and noxious gases exposure, of which cigarette smoking (CS) is considered as the predominant factor and attributed to approximately 80–90% of the COPD cases [2]. Airway epithelium serves as the first line of the innate immune defense against CS attack through the secretion of various pro-inflammatory mediators and production of airway mucus, whereas, the excessive accumulation of these immunological factors in chronic bronchiolitis caused by CS inhale contributes to the irreversible airflow limitation and airway remodeling, and COPD-related mortality occurs [3]. Furthermore, the CS-induced apoptosis in airway epithelial cells also accounts to the pathogenesis of COPD [4]. However, the molecular mechanism underlying the CS-induced inflammation and apoptosis in the progression of COPD remains largely unknown.

microRNAs (miRNAs) are a class of conserved and small non-coding RNAs (19-35 nucleotides in length) that negatively regulate gene expressions via complementary binding to the 3′-untranslated region (3′-UTR) of their target mRNAs, which results in the repression of protein synthesis and cleavage of mRNAs [5]. Emerging miRNA-microarray analysis has demonstrated that miRNAs play crucial roles in the pathogenesis of COPD [6]. miR-145-5p as a member of the miR-145 family has been widely verified to be involved in various human malignancies [7]. A recent study has illustrated that in myocardial ischemic injury, miR-145-5p functions as a cardiac-protective molecule by ameliorating apoptosis and inflammation [8]. Additionally, overexpression of miR-145 in airway smooth muscle cells from COPD patients has been manifested to suppress pro-inflammatory cytokines release when compared to the non-smoker controls [9]. However, the role and molecular mechanisms underlying the regulation of miR-145-5p on the inflammation and apoptosis of CS-stimulated airway epithelial cells are still poorly understood.

Kruppel-like 5 (KLF5, also named LKLF and BTEB2) is located at 13q21 chromosome and belongs to a family of zinc-finger (ZF) containing transcription factors. KLF5 is ubiquitously expressed at varying levels in different tissues, which facilitates the regulation of a wide range of genes involved in cell proliferation, apoptosis, stemness, inflammation, angiogenesis, migration, and differentiation [10]. A previous study has indicated that silencing of KLF5 prevents hypoxia-induced proliferation and migration, and promoted apoptosis in human pulmonary artery smooth muscle cells [11]. Specifically, KLF5 has been proved to be upregulated in the bronchial fibroblasts and pulmonary vessels of the patients and has a remarkably correlation with the severity of the airflow limitation [12]. Accordingly, we hypothesized that KLF5 might be involved in the progression of CS-induced COPD.

Whether the biological role of miR-145-5p in response to CS-induced airway epithelial cell dysfunction was mediated via KLF5 remain largely unknown. In this study, we identified miR-145-5p as a CS-induced apoptosis and inflammatory responsive miRNA in COPD patients and cells line. Further investigation revealed that miR-145-5p inhibited CS-induced apoptosis and inflammation in HBEC by negatively regulating of KLF5.

Section snippets

Human lung sample collection

Lung resection specimens were obtained from 31 patients underwent a pneumonectomy for a solitary non-small cell lung cancer (at least 5 cm away from the tumor regions) at The First Affiliated Hospital of Xi'an Jiaotong University. The subjects were divided into three groups: non-smokers without COPD (n = 8); smokers without COPD (n = 10), smokers with COPD (n = 13). The diagnosis of COPD was based on the criteria of the Global Initiative for Chronic Obstruct Lung Disease (GOLD). The

miR-145-5p was down-regulated in COPD tissues and CSE-mediated HBECs

The clinical characteristics including age and body mass index (BMI) among the three groups show no statistical difference except for lung function (Table 1). The expression of miR-145-5p in 31 cases of lung tissue samples were determined by qRT-PCR. Compared with specimens from non-smoker group, the expression level of miR-145-5p was remarkably reduced in lung tissues of smokers without or with COPD (P < 0.05 and P < 0.01, respectively, Fig. 1A). In addition, after exposure of HBECs to a

Discussion

Multiple studies have verified that persistent exposure to CSE contributed to the dysregulation of miRNAs in the lungs, which is associated with various respiratory disorders, such as pulmonary tuberculosis, asthma, lung cancers, as well as COPD [14]. Downregulation of miR-145 has been shown in the lungs of COPD rat model with CS exposure and miR-145 has been proposed to be closely associated with the diagnosis of COPD [9,15]. However, the function of miR-145-5p involved in the pathogenesis of

Conflicts of interest

The authors declare no conflicts of interest in this work.

Acknowledgement

This study was supported by “International Science and Technology Cooperation and Exchange Program Project of Shaanxi Province of China (2016KW-026).

References (37)

  • D.M. Comer et al.

    Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers

    Eur. Respir. J.

    (2013)
  • Z. Li et al.

    Therapeutic targeting of microRNAs: current status and future challenges

    Nat. Rev. Drug Discov.

    (2014)
  • M.E. Ezzie et al.

    Gene expression networks in COPD: microRNA and mRNA regulation

    Thorax

    (2012)
  • M. Yuan et al.

    MiR-145-5p regulates hypoxia-induced inflammatory response and apoptosis in cardiomyocytes by targeting CD40

    Mol. Cell. Biochem.

    (2017)
  • L. O'Leary et al.

    Airway smooth muscle inflammation is regulated by microRNA-145 in COPD

    FEBS Lett.

    (2016)
  • J.T. Dong et al.

    Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases

    Cell. Mol. Life Sci.

    (2009)
  • A. Courboulin et al.

    Kruppel-like factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension

    Respir. Res.

    (2011)
  • K. Abe et al.

    Possible role of Kruppel-like factor 5 in the remodeling of small airways and pulmonary vessels in chronic obstructive pulmonary disease

    Respir. Res.

    (2016)
  • Cited by (40)

    • Inhibition of miR-494-3p alleviates oxidative stress-induced cell senescence and inflammation in the primary epithelial cells of COPD patients

      2021, International Immunopharmacology
      Citation Excerpt :

      MiRNAs are reported to play a vital role in the pathogenesis of COPD by targeting multiple genes. MiR-145-5p is associated with smoke-related COPD and targets KLF5 [30]. MiR-132 has been found to contribute to the pathophysiology of COPD by targeting SOCS5.

    • Hsa_circ_0006872 promotes cigarette smoke-induced apoptosis, inflammation and oxidative stress in HPMECs and BEAS-2B cells through the miR-145-5p/NF-κB axis

      2021, Biochemical and Biophysical Research Communications
      Citation Excerpt :

      Herein, we disclosed that miR-145-5p level was prominently decreased in COPD patients. Furthermore, recent research unveiled that augmentation of miR-145-5p restrained CSE-triggered HBECs apoptosis and inflammation in COPD by interacting with KLF5 and regulating NF-κB signaling [30]. Gu et al. revealed that down-regulation of miR-145-5p overturned the inhibition of TUG1 depletion on CSE-stimulated inflammation and collagen deposition in HBE cells and lung fibroblasts [31].

    View all citing articles on Scopus
    View full text